ClinicalTrials.Veeva

Menu

Evaluation of a Soft Tissue Biopsy System for Trans-rectal and Trans-perineal Biopsy of the Prostate

U

Uro-1 Medical

Status

Not yet enrolling

Conditions

Prostate Disease

Treatments

Device: Prostate biopsy needle

Study type

Interventional

Funder types

Industry

Identifiers

NCT05470127
SUREcore v. SOC

Details and patient eligibility

About

Currently used biopsy devices do not predictably obtain full cores of tissue and the tissue obtained is often fragmented and disrupted making it difficult for pathological review. This post-market study will assess the utility of the SUREcore biopsy needle and the coreCARE specimen retrieval device versus a standard of care biopsy needle and the typical tissue container used in urology offices and clinics today.

Full description

The safety and performance of the SUREcore and coreCARE devices will be compared to matched prostate tissue collected with a standard of care biopsy needle and tissue retrieval system. Following informed consent, prostate tissue biopsy samples will be obtained using the systematic 12 core biopsy template-- 6 with the typical biopsy needle and 6 with the SUREcore needle. Tissue samples will be randomized to retrieval with the swiping method or using the coreCARE device. Adverse events will be documented both during the procedure and within 5 days after the procedure. The user will be asked to rank the use of both biopsy tools during the procedure and a pathologist will be asked to assess the quality of the tissue cores obtained.

Enrollment

50 estimated patients

Sex

Male

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult male scheduled for prostate biopsy
  • Able to provide informed consent
  • Able and willing to provide verbal assessment of his condition 5 days post-procedure

Exclusion criteria

  • Unwilling to provide consent

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

SUREcore biopsy needle
Experimental group
Description:
The SUREcore needle will be used to collect up to 10 tissue samples
Treatment:
Device: Prostate biopsy needle
Standard of Care biopsy needle
Active Comparator group
Description:
The urologist will use his/her standard biopsy needle to collect up to 15 tissue samples
Treatment:
Device: Prostate biopsy needle

Trial contacts and locations

0

Loading...

Central trial contact

Thomas Lawson, PhD; Jack Snoke

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems